FDA: Product quality issues fuel rise in drug shortages

"A very large number of quality product issues" is what Valerie Jensen, associate director for FDA's drug shortage program (CDER), cites as the major cause of the 178 shortages counted by the regulator in 2010. To be precise, product quality played a role in 54% of shortages. Some of the issues were sterility or impurities; others were production delays or capacity problems. "In 2011, we're seeing the same trend." Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.